Follicular and Hürthle cell carcinoma of the thyroid gland.
Follicular and Hürthle cell carcinoma of the thyroid gland are uncommon tumors that are genotypically similar. Current and future diagnostic adjuncts, treatment, and postoperative follow-up for patients with follicular and Hürthle cell cancer are outlined. Risk factors for recurrence and mortality and the reported outcomes of treatment of follicular and Hürthle cell carcinoma are reviewed.
Phitayakorn
Roy
R
Department of Surgery, MetroHealth Medical Center, Case Western Reserve University School of Medicine, 2500 MetroHealth Drive, Cleveland, OH 44109, USA.
McHenry
Christopher R
CR
D000236:Adenoma / Q000473:pathology / Q000601:surgery; D018249:Adenoma, Oxyphilic / Q000473:pathology / Q000601:surgery; D006801:Humans; D007457:Iodine Radioisotopes; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013954:Thyroglobulin / Q000097:blood; D013964:Thyroid Neoplasms / Q000473:pathology / Q000601:surgery; D013965:Thyroidectomy; D013972:Thyrotropin / Q000097:blood
D007457:Iodine Radioisotopes; D013972:Thyrotropin; D013954:Thyroglobulin